Exane Derivatives’s Fox Class B FOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.81K Sell
61
-1,851
-97% -$60.2K ﹤0.01% 451
2022
Q1
$69.4K Sell
1,912
-140
-7% -$5.21K 0.02% 523
2021
Q4
$70.3K Buy
2,052
+2,029
+8,822% +$74.3K 0.02% 471
2021
Q3
$854 Sell
23
-278
-92% -$9.53K ﹤0.01% 881
2021
Q2
$10.2K Sell
301
-1,821
-86% -$65.9K ﹤0.01% 743
2021
Q1
$74.1K Sell
2,122
-564
-21% -$18.9K 0.02% 466
2020
Q4
$77.6K Buy
+2,686
New +$74.4K 0.02% 427

Other funds holding FOX

Exane Derivatives's FOX Position: Q2 2022 in Review

Exane Derivatives reduced its Fox Class B (FOX) stake by 97% in Q2 2022, selling an estimated $60.2K and leaving 61 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

Exane Derivatives first reported a position in FOX in Q4 2020 and has held it in 7 quarters since. The position peaked at $77.6K in Q4 2020. 353 funds tracked by Wall St. Rank hold FOX as of Q2 2022.

  • Exane Derivatives held 61 shares of Fox Class B worth $1.81K as of Q2 2022.
  • Exane Derivatives sold 1,851 Fox Class B shares in Q2 2022, an estimated $60.2K.
  • Fox Class B made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #451 holding.
  • Exane Derivatives first reported a position in Fox Class B in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Fox Class B position peaked at $77.6K in Q4 2020.
  • 353 funds tracked by Wall St. Rank held Fox Class B as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.